Paloma Partners’s ImageneBio Inc IMA Stock Holding History

Paloma Partners’s Portfolio IMA Stock Details IMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,520	Closed	-$49.9K	–	1411
2024 Q2	$49.9K	Buy	+2,520	New	+$44.5K	﹤0.01%	1145

Other funds holding IMA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return

Paloma Partners's IMA Position: Q3 2024 in Review

Paloma Partners sold out of ImageneBio Inc (IMA) in Q3 2024, closing a stake of 2,520 shares — an estimated $49.9K sold.

Paloma Partners first reported a position in IMA in Q2 2024 and held it in 1 quarter. The position peaked at $49.9K in Q2 2024. 57 funds tracked by Wall St. Rank hold IMA as of Q3 2024.

Paloma Partners reported no remaining ImageneBio Inc position as of Q3 2024 after selling out during the quarter.
Paloma Partners sold 2,520 ImageneBio Inc shares in Q3 2024, an estimated $49.9K.
Paloma Partners first reported a position in ImageneBio Inc in Q2 2024 and held it in 1 quarter.
Paloma Partners's ImageneBio Inc position peaked at $49.9K in Q2 2024.
57 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2024.

Based on Paloma Partners's 13F filing for Q3 2024, filed 14 Nov 2024.